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In recent years, a number of large-scale genome-wide association studies have been published for human traits adjusted for other corre-
lated traits with a genetic basis. Inmost studies, the motivation for such an adjustment is to discover genetic variants associated with the
primary outcome independently of the correlated trait. In this report, we contend that this objective is fulfilled when the tested variants
have no effect on the covariate or when the correlation between the covariate and the outcome is fully explained by a direct effect of the
covariate on the outcome. For all other scenarios, an unintended bias is introduced with respect to the primary outcome as a result of the
adjustment, and this bias might lead to false positives. Here, we illustrate this point by providing examples from published genome-wide
association studies, including large meta-analysis of waist-to-hip ratio and waist circumference adjusted for body mass index (BMI),
where genetic effects might be biased as a result of adjustment for body mass index. Using both theory and simulations, we explore
this phenomenon in detail and discuss the ramifications for future genome-wide association studies of correlated traits and diseases.Adjustment for covariates or correlated secondary traits in
genome-wide association studies (GWASs) can have two
purposes: first, to account for potential confounding fac-
tors that can bias SNP effect estimates, and second, to
improve statistical power by reducing residual variance.
For example, researchers routinely adjust for principal
components of individual genotypes to account for popu-
lation structure,1 or principal components of gene expres-
sion to capture batch effects in gene-expression analysis.2
Besides confounding factors, human traits can also be
adjusted for correlated environmental or demographic fac-
tors such as gender and age to increase statistical power.3,4
The intuition here is that accounting for a true risk factor
decreases the residual variance of the outcome and there-
fore increases the ratio of the true effect size of a predictor
of interest over the total phenotypic variance, which leads
to increased statistical power.
Recently, researchers have conducted GWAS of human
traits and diseases while adjusting for other heritable cova-
riates with the motivation of identifying genetic variants
associated only with the primary outcome.5–9 An impor-
tant difference between environmental/demographic
factors and heritable human traits is that the latter have
genetic associations. Therefore, a genetic variant can in
theory be associated with both the primary outcome and
the covariate used for adjustment. When that happens,
the adjusted and unadjusted estimated effects of the ge-
netic variant on the outcome will differ. If the correlation
between the covariate and the outcome results from a
direct effect of the covariate on the outcome (Figure 1A),
the adjusted and unadjusted estimates correspond to the
direct (i.e., not mediated through the covariate) and total
(i.e., direct þ indirect) genetic effect of the variant on the
outcome, respectively. In all other situations where the
observed correlation is due to shared genetic and/or envi-1Department of Epidemiology, Harvard School of Public Health, Boston, MA 0
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The Americronmental risk factors, the adjusted estimate can be biased
relative to the true direct effect.
To understand when a bias is introduced, consider the
causal diagrams for a single genetic variant g, an outcome
of interest Y, and a covariate C (Figures 1B–1D). Besides
the genetic variant in question, the two variables, Y and
C, are influenced by either other genetic loci, which we
denote by G-g, or other environment factors and noise, de-
noted by E. For simplicity, assume that the genetic variant g
and other causal factors, G-g and E, are uncorrelated.
Furthermore, assume that the covariate C and the outcome
of interest, Y are correlated through (G-g,E). If we are inter-
ested in estimating the direct effect of g on Y (the black ar-
row in Figure 1), then in scenario from Figure 1B adjusting
for the covariate C does not bias the effect estimate and in-
creases the power as we implicitly adjust for some environ-
mental and other (uncorrelated) shared genetic effects.
However, in scenario from Figure 1C where g only influ-
ences the covariate and not the outcome, adjusting for
the covariate induces an association between the genetic
variant and Y. The strength of this association depends
on rCY, the correlation between the covariate and the
outcome due to shared risk factors, and the strength of
bC, the effect of the genetic variant on the covariate. For
normalized g, C, and Y with mean 0 and variance 1, the
bias of the genetic effect estimate, bbY , on the covariate
adjusted trait is approximately equal to bCrCY when bC
is small and sample size is sufficiently large (see
Appendix A). Finally, consider scenario from Figure 1D,
where both the covariate and the outcome are influenced
by the genetic variant. Here, the association between the
genetic variant and the covariate will bias the estimated
genetic effect on the outcome by the same amount as
before, i.e., bCrCY. This bias observed is illustrated in
Figure 2A, and as expected, it is well approximated by2115, USA
y of Human Genetics. All rights reserved.
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Figure 1. Underlying Causal Diagrams
Four causal diagrams describing the causal
relationship between the genotypes G,
environment E, a covariate C, and the
outcome of interest Y are shown. In (A),
the correlation between Y and C is due
to a direct effect of C on Y, whereas in
(B)–(D,) the correlation between Y and C
is explained by shared risk factors.the product between the direct genetic effect estimate on
the covariate and the correlation between the outcome
and the covariate. As shown in Figure 2B, this bias leads
to increased false discovery rates under the null (no direct
effect of the genetic variant on the outcome). This phe-
nomenon also implies that when there truly is a direct
genetic effect on the outcome, the adjusted statistical test
can have increased power to detect the genetic variant, as
compared to the unadjusted test, if the genetic effect and
the phenotypic correlation are in opposite directions
(Figure S2, left panel). Conversely, if the genetic effect
and the correlation are in the same direction, the adjusted
statistical test has, in many cases, a decreased power to
detect the genetic variant (Figure S2, right panel).
The difficulty of estimating direct effects of genetic var-
iants on a covariate-adjusted outcome is well appreciated
in causal inference literature10 and by many epidemiolo-
gists,11–13 but has received little attention in the context
of GWASs.14 In Appendix B, we review 15 scenarios de-
picted as direct acyclic graphs in Figure S1 where adjust-
ing for a covariate is either recommended or not and vali-
dated the interpretation of each case through simulation
(see Table S3). In the absence of a clear underlying causal
model or diagram, one cannot guarantee that effect esti-
mates for covariate adjusted outcomes correspond to the
desired estimates (e.g., direct versus total genetic effect).
In GWASs, the potential presence of bias due to adjust-
ment is proportional to the product of bC and rCY. Hence,
adjusting for a covariate that does not have a genetic
component, such as an environmental exposure, will
not bias the estimate for the genotype effect on the
outcome of interest as bC ¼ 0. On the other hand, when
adjusting for a covariate that has a genetic component
(potentially bCs 0), then the adjusted association signals
can be difficult to interpret, because it does not necessarily
imply an association with the outcome of interest only
but can correspond also to a bivariate signal on Y and C,
or in some extreme case to an association with the covar-
iate only. Therefore, unless we can unequivocally deter-
mine which model in Figure 1 is the right one or rule
out an effect from the genetic variant on the covariate,
the reported adjusted associations should be considered
with caution.
For illustrative purpose, we considered the SNPs reported
to be associated at genome-wide significance levels with
waist hip ratio (WHR) or waist circumference (WC), after330 The American Journal of Human Genetics 96, 329–339, Februaryadjustment on BMI.6,8 The observed correlations between
BMI and WHR and between BMI and WC in the GIANT
data are 0.49 and 0.85, respectively (see Appendix C).
Table 1 displays the gender-specific significant SNPs from
these studies and the summary statistics that we extracted
from the GIANT consortium website. It shows that SNPs
harboring opposite marginal effects on the two traits are
significantly enriched (p ¼ 0.005). This agrees well with
theory and our simulations showing increased power
when the SNP has effect in opposite directions on the
outcome and the covariate (Figure S2A). In the absence
of a genetic effect on BMI, we expect the number of SNPs
with opposite directions of effect estimates to follow a
binomial distribution with probability of 0.5 (see Appen-
dix C and Figure S3). The observed enrichment of SNPs
with opposite directions indicates that a substantial frac-
tion of those SNPs are associated with BMI in the opposite
direction. Indeed, when removing the SNPs with the most
significant marginal associations with BMI, the fraction of
variants displaying an opposite effect becomes non-signif-
icant (Figure S4). None of the SNPs with opposite effects on
BMI and either WHR or WC show significant marginal as-
sociation with BMI after correction for multiple testing
(although 5 out of 23 are nominally significant). However,
as shown in Figure S2B, even non-significant genetic
effects on the covariate can influence power when corre-
lation between the outcome and the covariate is large
(e.g.,R 0.5).
To assess whether the p values from the adjusted analysis
reflect direct genetic effects on the outcome or a mixture of
effects on the outcome and the covariate, we derived a
statistical test of whether the BMI-adjusted effect of a
SNP, bbYadj, was equal to its expectation when bC¼ 0, which
is bbY . This test only uses GWAS summary information and
the correlation between the covariate and the phenotype
(see Appendix A). It is approximately equivalent to testing
for the marginal effect of the SNP on the covariate in the
exact same set of subjects used in the adjusted analysis.
To verify this, we conducted a GWAS of WHR, BMI, and
WHR adjusted for BMI for 15,949 individuals on more
than 6 million SNPs and found the correlation between
the two test statistics, the direct marginal and the proposed
one based on GWAS summary level information, to be
0.98 (see Appendix A). We then applied our test to the
WHR and WC GWAS summary statistics to test for a direct
genetic effect on BMI among the reported SNP associations5, 2015
Figure 2. Effect Estimates and False Discovery
Rate
Results for simulations of correlated outcomes and
covariates and a genetic variant that influences the
covariate only are shown. In (A), the average
observed bias of the genetic effect estimate in the co-
variate adjusted analysis is plotted as a function of
the correlation between the outcome and the covar-
iate for different values of direct genetic effect on
the covariate. The dashed lines correspond to the
theoretical bias as derived in the method section.
In (B), the average false discovery rate (a ¼ 0.05) of
over 5,000 replicates is plotted as a function of rY,C
the correlation between the outcome and the covar-
iate for different values of direct genetic effect on
the covariate when simulating 2,000 individuals.from the GIANT study (see Table 1) as we did not have ac-
cess to the marginal associations for BMI in the same sam-
ples. We observed that half of the reported associations
with WHR adjusted for BMI are likely influenced by a
(direct) genetic association with BMI. This does not mean
that those SNPs have no effect on WHR; in fact, their mar-
ginal (unadjusted) associations withWHR and BMI suggest
that most of these loci are truly associated with WHR.
Instead, this means that the reported effect estimates
and the p values in the covariate adjusted analysis should
be interpreted with caution, because they are not neces-
sarily representative of the direct genetic effect on WHR
and WC.
We extended our analysis to other GWAS of covariate
adjusted outcomes and found evidence that reported ge-
netic associations with the primary outcome were in part
explained by the effect of the SNP on the covariate. For
example, the SNP rs11977526 has been reported to be asso-
ciated with insulin-like growth factor-binding protein-3
(IGFBP3 [MIM 146732]) at very high significance level
3.3 3 10101 while no association was observed for Insu-
lin-like growth factor-I (IGF1 [MIM 147440]) before any
adjustment.5 The IGF1 analysis adjusted for IGFBP3 dis-
plays a genetic association with rs11977526 (p ¼ 1.9 3
1026) with estimate going in the opposite direction of
the rs11977526/IGFBP3 association while IGFBP3 and
IGF1 are positively correlated (>0.7).15,16 This indicates
that the observed rs11977526/IGF1adj.IGFBP-3 association
is likely driven by the rs11977526/IGFBP3 association. In
a secondary analysis, Thorleifsson et al.17 tested whether
SNPs found to be associated with BMI or weight wereThe American Journal of Halso associated with type 2 diabetes (T2D)
with or without adjustment for BMI. Most p
values for association between those SNPs
and T2D were less significant after adjustment
for BMI, consistent with a direct effect of BMI
on T2D; i.e., BMI is a mediator of the genetic
effect (Figure 1A). However, a handful of
them had opposite effects, which increased
signal in the adjusted analysis (see Table S1).
Those signals might be partly explainedby the genetic association with BMI, indicating that Fig-
ures 1C and 1D might fit the data as well. However, this
analysis was conducted on case-control data, ascertained
to oversample T2D cases, raising additional complexities
in the interpretation of these results.4,18 Several other
large-scale heritable-trait-adjusted GWAS have been con-
ducted.9,19–21 Among those we explored, all displayed
enrichment for genetic variants showing nominal signifi-
cance association with the covariate considered, genetic
variants with opposite effect on the outcome and the
covariate, or both (see Table S2).
Finally, this concept of biased associations in covariate
adjusted analysis can be extended to other effect mea-
sures. In particular, the heritability of a phenotype
adjusted for a covariate, commonly reported,22–26 can
also be biased by the genetic component of the covariate
and therefore might not necessarily represent the genetic
component of the primary outcome. Similarly cross-trait
heritability or genetic correlations between covariate
adjusted phenotypes, as measured by Lee et al.,27 might
also be biased. Assuming an extended model from
Figure 1D, the genetic component of the adjusted trait
would correspond to a heterogeneous mixture of trait-spe-
cific genetic loci and shared loci with either effect in the
same direction or effect in opposite direction (Figure 3).
In theory, one can expect the heritability of an adjusted
trait to be larger than the heritability of the unadjusted
trait (Figure 3C). Cross-trait heritability estimates would
provide a more comprehensive answer to the genetic vari-
ance overlap between correlated traits, although it is un-
clear how genetic effects in opposite direction foruman Genetics 96, 329–339, February 5, 2015 331
Table 1. Estimates and p Values of Genetic Effects from the GIANT Study for Genetic Variants Found Associated with Waist to Hip Ratio
and Waist Circumference after Adjusting for Body Mass Index
MarkerName A1 A2 Frequency Estimated Effects
Opposite
Effect Reference Pb.deviation
a
WHR adjusted for BMI in women BMI (pval) WHR (pval) WHRadjBMI (pval)
rs9491696 c g 0.4800 0.0068 (2.7E-01) 0.0479 (1.0E-11) 0.0472 (1.6E-12) Heid et al. 0.81
rs6905288 a g 0.5620 0.0083 (2.4E-01) 0.0484 (4.7E-10) 0.0523 (7.7E-13) X Heid et al. 0.22
rs984222 c g 0.6350 0.0108 (8.5E-02) -0.0284 (9.0E-05) -0.0359 (1.2E-07) X Heid et al. 0.012
rs1055144 t c 0.2100 -0.0126 (1.1E-01) 0.0314 (4.2E-04) 0.0398 (2.3E-06) X Heid et al. 0.021
rs10195252 t c 0.5990 -0.0184 (3.3E-03) 0.0447 (7.0E-10) 0.0529 (6.3E-15) X Heid et al. 0.0061
rs4846567 t g 0.7170 0.0098 (1.4E-01) -0.0543 (5.3E-12) -0.0641 (4.7E-18) X Heid et al. 0.0025
rs1011731 a g 0.4280 0.0058 (3.5E-01) 0.0280 (7.0E-05) 0.0284 (2.1E-05) Heid et al. 0.89
rs718314 a g 0.2590 0.0077 (2.7E-01) 0.0444 (3.9E-08) 0.0467 (8.3E-10) X Heid et al. 0.49
rs1294421 t g 0.6130 0.0007 (9.1E-01) 0.0357 (1.2E-06) 0.0380 (3.4E-08) Heid et al. 0.45
rs1443512 a c 0.2390 0.0014 (8.5E-01) 0.0415 (7.6E-07) 0.0479 (1.4E-09) X Heid et al. 0.063
rs6795735 t c 0.5940 0.0114 (6.4E-02) -0.0264 (2.2E-04) -0.0330 (7.9E-07) X Heid et al. 0.023
rs4823006 a g 0.5690 0.0046 (4.6E-01) 0.0337 (3.4E-06) 0.0366 (6.9E-08) Heid et al. 0.33
rs6717858 t c 0.5417 -0.0185 (3.1E-03) 0.0439 (8.1E-10) 0.0536 (2.8E-15) X Randall et al. 0.00072
rs2820443 t c . -0.0099 (1.4E-01) 0.0544 (4.8E-12) 0.0643 (3.7E-18) X Randall et al. 0.0025
rs1358980 t c 0.4500 -0.0148 (3.8E-02) 0.0498 (7.1E-10) 0.0565 (1.1E-13) X Randall et al. 0.041
rs2371767 c g 0.2083 0.0199 (4.1E-03) -0.0302 (1.2E-04) -0.0418 (1.6E-08) X Randall et al. 0.00040
rs10478424 a t 0.7833 0.0052 (5.1E-01) 0.0320 (3.3E-04) 0.0372 (1.0E-05) X Randall et al. 0.16
rs4684854 c g 0.4333 0.0025 (7.0E-01) 0.0401 (7.6E-08) 0.0396 (2.4E-08) Randall et al. 0.88
WC adjusted for BMI in women BMI (pval) WC (pval) WCadjBMI (pval)
rs11743303 a g 0.8 0.0078 (3.2E-01) 0.0186 (3.7E-02) 0.0276 (2.3E-06) X Randall et al. 0.12
WHR adjusted for BMI in men BMI (pval) WHR (pval) WHRadjBMI (pval)
rs9491696 c g 0.4800 0.0004 (9.5E-01) 0.0295 (1.1E-04) 0.0255 (1.7E-04) X Randall et al. 0.26
rs984222 c g 0.6350 0.0146 (2.4E-02) -0.0299 (1.3E-04) -0.0407 (3.3E-09) X Randall et al. 0.0030
rs1055144 t c 0.2100 0.0007 (9.3E-01) 0.0273 (4.3E-03) 0.0289 (6.0E-04) X Randall et al. 0.72
rs1011731 a g 0.4280 0.0082 (2.0E-01) 0.0307 (5.4E-05) 0.0341 (4.9E-07) X Randall et al. 0.34
SNPs nominally significant for the test of bias (Pb.deviation < 0.05) are indicated in bold.
ap value from the test of bbYadj ¼ bbY .positively correlated traits (or conversely) are handled by
these methods.
Overall, when the goal is to identify genetic variants
that are directly associated with a primary outcome, we
were unable to identify an alternative approach that ad-
justs for a covariate and leads to unbiased effect estimates
for a heritable covariate that is associated with the tested
variant (see Appendix D). Therefore, unless we know with
certainty that the tested variant does not influence the co-
variate, we recommend that the inclusion of such herita-
ble covariates in the model should be avoided. Given ev-
idence for a large number of pleiotropic genes across
complex traits,28–30 it seems unlikely that any heritable
covariates with a complex genetic architecture, e.g., BMI332 The American Journal of Human Genetics 96, 329–339, Februaryor WHR, will fulfill that condition. Including such covari-
ates in the absence of a strong prior knowledge on the
pathophysiology is therefore likely to lead to biased effect
estimates.
In some instances, the aim of an adjusted analysis is
to increase statistical power rather than detect unbiased
direct effects. In these instances, we suggest using multi-
variate approaches31–33 that do not assume a causal dia-
gram. Such approaches are generally well powered to
detect pleiotropic loci affecting multiple traits, which
are exactly the type of loci where we might expect the
most power gain from adjusted analysis. However, if
adjusted analyses are performed, we recommend report-
ing genetic effect estimates on the covariate and the5, 2015
Figure 3. Heritability of Adjusted Phenotypes
We compared the heritability of a given phenotype against the heritability estimated after adjustment for a correlated variable. We simu-
lated a trait Y adjusted for a correlated trait C. The genetic variance of each trait (upper panel) splits into trait-specific effects, shared ef-
fects, and shared loci with opposite effects. We vary heritability of Y and C from 0.8 (A), 0.5 (B), and 0.2 (C) and the proportion of shared
environmental variance (bottom panel) from 0 to 1.outcome before and after the adjustment, their SD and
significance, as well as the correlation between the
outcome and the covariate. With this information in
hand, the magnitude of a potential bias can be esti-
mated and taken into account when interpreting the
results.Appendix A
Model
For simplicity we assume a linear model instead of a lo-
gistic model, which is often used for GWAS of case-con-
trol disease traits. However, the least-square estimates
from a linear regression are a scaled first-order approxi-
mate of the log-odds obtained from a logistic regres-
sion.4 Therefore, given sufficient sample size, the issue
highlighted in this letter also holds for case-control data-
sets when analyzed with logistic regression. Following
the notation described in Figure 1, we can write the
true causal model for the covariate C and the outcome
Y as C ¼ bCg þ uC, and Y ¼ bYg þ uY, where uC and uY
denote the combined contribution due to other loci, as
well as the respective environmental (and noise) compo-
nents of the covariate and the outcome. Note that this
model does not rule out a direct contribution from C
on Y (or vice versa), which could be included in the uC
and uY terms, respectively. However, such an effect could
affect the interpretation of the direct effect estimates
mentioned here (see Appendix B). If we assume that
the covariate, the outcome, and the genotype have all
been normalized to have mean zero and variance one,
then we can write the marginal estimates for the genetic
effects as bbY ¼ g 0Y=n, and bbC ¼ g 0C=n, where n is the
sample size. Similarly, the correlation coefficient can be
written as brCY ¼ C0Y=n. Finally, we can write the adjusted
model as Y ¼ aC þ bYadjg þ e, where a denotes the effect
of C on Y, bYadj the genetic effect, and e the environment
(noise) term. Note that we do not believe that this is theThe Americgenerative model, rather the model that is being em-
ployed when performing GWAS on covariate adjusted
outcomes.Bias of the Effect Estimates in the Covariate
Adjusted Model
From the adjusted model above we derived a joint least
square estimates for the effect of C and g on Y, i.e.,bb ¼  babbYadj

, which can be written as bb ¼ ðX0XÞ1X0y,
where X is a matrix composed of c and g, the realization
of C and g in a sample of n individuals, and y is a vector
of realization of Y in the same sample. When C, Y and
g are normally distributed with mean 0 and variance 1, bb
can be re-written as
bb ¼ ½c;g0 ½c;g1½c;g0y
bb ¼  c0c c0g
g0c g0g
1
½c;g0y
bb ¼  n nbbC
nbbC n
1
½c;g0y
bb ¼ 1
n2  n2bb2C

n nbbC
nbbC n

½c;g0y
bb ¼ 1
n nbb2C
h
c bbCg;bbCcþ gi0y
bb ¼
26664
1
n nbb2C

c bbCg 0y
1
n nbb2C

bbCcþ g0y
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bb ¼
26664
1
n nbb2C

c0y bbCg 0y
1
n nbb2C

 bbCc0yþ g 0y
37775
bb ¼
26664
1
n nbb2C

nbrCY  bbCnbbY
1
n nbb2C

 bbCnbrCYþ nbbY
37775
bb ¼
26664
1
1 bb2C
brCY  bbCbbY 
1
1 bb2C

 bbCbrCY þ bbY
37775:
Assuming bb2C  1, which is expected for most human
phenotypes, including BMI, WHR, and WC the estimated
effect of g can be approximated by bbYadjz bbCbrCY þ bbY.
And therefore for a sample size n the expected value ofbbYadj can be approximated by
E
bbYadjzE bbCbrCY þ bbYzE bbCbrCY
þ E
bbYz bC3 rCY þ covbbC; brCYþ bY :
Since brCY ¼ corðC;YÞ ¼ corðbbCg þ εC; bbYg þ εYÞ ¼bbCbbY þ gres, where gres is the correlation between C and Y
not explained by the SNP in the data, EðbbYadjÞ can be re-
written as
E
bbYadjz bC3 rCY þ covbbC; bbCbbY þ gresþ bY
E
bbYadjz bC3 rCY þ covbbC; bbCbbYþ bY
E
bbYadjz bC3 rCY þ s2bbC 3E
bbYþ bY
E
bbYadjz bC3 rCY þ bYn þ bY :
For large sample size (e.g., n> 1000), EðbbYadjÞ can thus be
approximated by bY bC 3 rCY. It implies that EðbbYadjÞzbYVar
bbYadj j bC ¼ 0; bbY ¼ bbY ; brCY ¼ brCY ¼ Var
 
1
1 bb2C j bC
þ Var
 
1
1 bb2C j b
þ Var
bbY  bbCbr
334 The American Journal of Human Genetics 96, 329–339, Februarywhen bC ¼ 0, and is therefore unbiased; however, when
bC s 0, using C as a covariate when testing the effect of
G on Y introduce a bias approximately equal to bC 3
rCY, which depends on the marginal effect of the genetic
variant on the covariate and the correlation coefficient be-
tween the covariate and the outcome.
Finally, one can note that brCY cannot be null when bothbbY and bbC are not null. Hence in the special case where brCY
is only explained by the shared genetic effect of g on Y and
C, brCY equals brCY ¼ corðC;YÞ ¼ corðbbCg þ εC; bbYg þ εYÞ,
where εC and εY are independent residual normally distrib-
uted with mean 0 and variance ð1 bb2CÞ and ð1 bb2YÞ;
respectively. It follows that
brCY ¼ bbC3 bbY 3 corðg; gÞ þ bbC3 corðg; εYÞ þ bbY 3 corðg; εCÞ
þ corðεY ; εCÞ ¼ bbC3 bbY :
In such case the joint estimates becomes
bb ¼
264 01
1 bb2C ðbbY  bb
2
C
bbYÞ
375 ¼  0bbY

and the estimated
effects of g on Y before and after adjusting for C are equal.Testing for a Bias in the Covariate Adjusted Analysis
Given the joint least-square estimates above, we can
now write out their conditional distributions and make
use of them to test different hypothesis. The hypothesis
of interest is to test whether the observed association in
the covariate adjusted model is expected when there is
no direct genetic effect on C. In light of the equations
above, a simple test for the bias is a test for a marginal
association between the genetic variant and C, i.e., a test
for bC ¼ 0. However, if we are unable to perform the
marginal test, or if the reported values are calculated
using a different sample, we can approximate the
marginal test using only GWAS summary statisticsbbYadj, bbY , and the reported correlation brCY . In particular,
we are interested in the distribution of the joint
least square estimate for the genotype effect in the
covariate adjusted model under the null (bC ¼ 0).
We can treat bbY as an observed value, and get
EðbbYadjbC ¼ 0; bbY ¼ bbY ; brCY ¼ brCYÞ ¼ bbY and its vari-
ance, which equals¼ 0; bbY ; brCY
!
3Var
bbY  bbCbrCY j bC ¼ 0; bbY ; brCY
C ¼ 0; bbY ; brCY
!
3

E
bbY  bbCbrCY j bC ¼ 0; bbY ; brCY2
CY j bC ¼ 0; bbY ; brCY3
 
E
 
1
1 bb2C j bC ¼ 0; bbY ; brCY
!!2
:
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Because VarðbbY  bbCbrCY bC ¼ 0; bbY ; brCYÞ ¼ VarðbbCbrCY j
bC ¼ 0; brCYÞ ¼ br2CY=n and Varð1=1 bb2CjbC¼0; bbY ; brCYÞ ¼
Varð1=1 bb2CjbC ¼ 0Þz0 and Eð1=1 bb2CjbC ¼ 0Þz1 when
sample size n is large, we have
Var
bbYadj j bC ¼ 0; bbY ; brCY ¼ Var
 
1
1 bb2C j bC ¼ 0
!
3
br2CY
n
þ Var
 
1
1 bb2C j bC ¼ 0
!
3 bb2Y þ br2CYn
3
 
E
 
1
1 bb2C j bC ¼ 0
!!2
Var
bbYadj j bC ¼ 0; bbY ; brCY ¼zbr2CYn :
Using simulations, we verified that this is a very good
approximation of the variance for realistic sample sizes,
i.e., n > 1,000 (see Figure 2). Now that we have the mean
and the variance conditional on bC ¼ 0, we can use a
Wald test to test for a bias, i.e., test whether bC s 0. The
Wald test statistic then becomes nðbbYadj  bbYÞ2=br2CY . This
test only requires the reported GWAS summary statistics,
i.e., bbYadj, bbY , the reported correlation brCY , but not themar-
ginal in-sample effect estimate bbC. Since in-sample correla-
tion estimates, br2CY , may not be available there is a risk that
the statistic is mis-calibrated by a constant factor where
small values of br2CY can lead to false positives.
One can also note that the non-centrality parameter
(ncp) of the above Wald test can be expressed as
ncp ¼
n
0@ðbbC3brCY þ bbYÞ  bbY
1 bb2C
1A2
br2CY ¼ n
bb2C
1 bb2C, which corre-
sponds to the ncp of the association test between G on C
in the same sample.
We also confirmed the validity of the proposed test by
analyzing a real data of 15,949 individuals from three co-
horts, the Nurse’s Health Study, the Health Professional
Study and the Physicians’ Health Study. We performed a
genome-wide meta-analysis of WHR, BMI, and WHR
adjusted for BMI across 6,106,189 SNPs either genotyped
or imputed using the 1,000 genome reference panel.34
All analyses were adjusted for relevant covariates
including age, gender and the top 5 principal component
of the genotypes. This analysis confirmed first that the
difference in the genetic effect estimates from the BMI-
adjusted and non-adjusted analysis of WHR directly
depends on the genetic effect estimate on BMI and the
correlation between WHR and BMI. Indeed, after account-
ing for BMI and WHR variances, we observed that
ðbbYadj  bbYÞ  ðbbC3brCYÞ. We further compared the chi-
square statistics from the proposed test:
ðbbYadj  bbYÞ=ðsbbY3brCYÞ2 with the chi-square of the test
The Americof SNPs on BMI ðbbC=sbbCÞ2. We observed a correlation of
0.98 between the two chi-squares, thus confirming the
validity of the proposed test.
Proportion of Genetic Component
We derived the proportion of variance of an adjusted trait
by each genetic component of the primary outcome and
the covariate used for adjustment. Assume two normally
distributed traits Y and C with mean 0 and variance 1,
that have common and specific environmental compo-
nent Es, E1 and E2 respectively, a shared genetic compo-
nent with effect in the same direction Gs and in opposite
direction Go respectively, and trait-specific genetic compo-
nents G1 and G2 for Y and C respectively, so that
Y ¼ ﬃﬃcp 3Es þ ﬃﬃep 3E1 þ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1 c  ep 3 ﬃﬃﬃﬃgsp 3Gs þ ﬃﬃﬃﬃgop 3Go
þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 gs  go
p
3G1

C ¼ ﬃﬃcp 3Es þ ﬃﬃep 3E2 þ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1 c  ep 3 ﬃﬃﬃﬃgsp 3Gs  ﬃﬃﬃﬃgop 3Go
þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 gs  go
p
3G2

The adjustment of Y for C is defined as YadjC ¼ Y  aC
where a, the correlation between the two traits equals
cþ (1 c e) * (gs go). The proportion of variance of YadjC
explained by each of the four genetic component is then
vGs ¼ ð1 c  eÞ3 gs3
ð1 aÞ2
1 a2
vGo ¼ ð1 c  eÞ3 go3
ð1þ aÞ2
1 a2
vG1 ¼ ð1 c  eÞ3 ð1 gs  goÞ3
1
1 a2
vG2 ¼ ð1 c  eÞ3 ð1 gs  goÞ3
a2
1 a2Appendix B
Direct Acyclic Graphs and Interpretation of Adjusted
Analysis
The use of causal diagrams or directed acyclic graphs
(DAGs) in epidemiological research has been discussed
in detail by many authors previously.11–13,35 In this
note, we summarize parts of their work that are relevant
in the context of genetic epidemiology. The characteriza-
tion of inter-relationships between the SNP (g), correlated
trait (C), primary outcome (Y) and other relevant
measured/unmeasured (U) variables with the help of
causal diagrams or directed acyclic graphs (DAGs) can
help understand whether an adjustment might be
necessary (to avoid or reduce bias), unnecessary (increase
variance of effect estimates), or harmful (lead to bias).
We detail further 15 different DAGs (Figure S1)an Journal of Human Genetics 96, 329–339, February 5, 2015 335
corresponding to four different scenarios where adjusting
for a covariate is either recommended or should be
avoided. We confirmed the validity of each through simu-
lation (Table S3).
In general, when the exposure (in this case ‘‘g’’) and the
outcome share a common cause, adjustment for that
variable (C, Figure S1A) or a surrogate of that variable (C is
a surrogate for U, Figures S1B–S1D) is necessary.13 This
adjustment can remove the confounding effect due to the
common cause, although when the covariate is only a sur-
rogate, it will not completely solve the confounding issue
(Figure S1B and Table S3). Such a scenario is unlikely in ge-
netic epidemiological studies, since very few factors precede
the occurrence/acquisition of germline genetic variants.
Themain example of an upstream factor that influences ge-
notype distribution is population stratification; adjustment
for principal components can reduce the effects of popula-
tion stratificationbias. Therefore, it canbe argued that inor-
der to reduce confounding of the genetic effect on the pri-
mary outcome in genetic epidemiological studies, it is
rarely necessary to adjust for anything more than principal
components (adjustment for additional covariates in
certain situations can increase power, however4).
Next, we consider a scenario where the effect of the G on
Y is hypothesized to be completely or partially mediated
through C, or equivalently when C is a surrogate for a
mediator. Such a mediation is represented in causal dia-
grams by an indirect, unblocked path that goes through
C, or through factors tagged by C (Figures S1E–S1H).
Here, classical epidemiologists advise against adjustment
for C, since C is in the causal pathway and hence not a
confounder.12,13 In contrast, instances can be found where
genetic epidemiologists seek the controlled direct causal ef-
fect of G on Y by noting their intent to identify variants
associated with the outcome without covariate mediation,
and are thereby justified in adjusting for C, in the absence
of an unmeasured confounder36 described in the next
paragraph. In Figures S1E–S1H, there are two paths from
G to Y—a direct path and an indirect path that goes
through C. Statistical models that condition for C block
the path through C and reveal only the direct effect of G
on Y. We also note that when the covariate is only a surro-
gate for the mediator, the interpretation can be difficult as
the proportion of the ‘‘true’’ indirect path removed is un-
known (Figure S1h and Table S3)
However, if an unmeasured variable U, not considered in
the study, influences both C and Y, adjusting for C will
result in the formation of a backdoor path fromG to Y (Fig-
ures S1I and S1J). This path does not follow the direction of
the arrows and is blocked at C. Whenever a path is blocked
at a variable, that variable is termed a collider. Statistical
models that condition for colliders (or their descendants)
on a path from G to Y unblock that path, and can result
in biased effect estimate of G on Y.11,13 In a scenario where
C and Y both influence a collider U (Figure S1K), because C
is not a descendant of U, adjusting for C will not lead to
bias, but is at the same time unnecessary.336 The American Journal of Human Genetics 96, 329–339, FebruaryLastly, let us consider scenarios where, due to incom-
plete understanding of complex traits and unbeknownst
to investigators, C is a descendant of Y (Figures S1L–
S1O). In such a scenario, the indirect path from G to Y
will be blocked, and adjustment for C could result in
spurious associations due to opening of that backdoor
path. One possible example of a study where the adjust-
ment covariate might be the descendant of the primary
outcome is the GWAS of pro-insulin levels adjusted for in-
sulin—in biological pathways, insulin is produced from
pro-insulin by removal of the C-peptide,37 and hence insu-
lin levels might be influenced by pro-insulin levels.
Therefore, adjustment of insulin levels would not lead to
identification of SNPs associated with pro-insulin alone,
but some of the identified SNPs may be related to the
downstream process of conversion from pro-insulin to
insulin.
In summary, if an indirect path from G to Y is not
blocked, adjustment for C on the path could be utilized
to get an estimate of direct association between G and Y.
On the other hand, if the indirect path between G and Y
is blocked, adjustment for colliders (or their descendants)
in the path could result in biased estimates. More complex
scenarios might arise and might be resolved by applying
principles described in previous literature.11,13Appendix C
Analysis of the GIANT Data
We considered for illustrative purpose the 23 SNPs reported
to be associated at genome-wide significance levels in
gender specific samples with waist hip ratio (WHR) and
waist circumference (WC) after adjustment on body mass
index (BMI) by Heid et al.6 and Randal et al.8 We extracted
from the GIANT summary statistics database the estimated
effects of those SNPs on WHR, or WC when relevant,
before and after adjustment for BMI, and the marginal ef-
fect of those SNPs on BMI. All estimates were selected
from the sex stratified anthropometrics analysis.8 The sam-
ple sizes (averaged over all SNPs) used for each of the 6 an-
alyses were as follows: for BMI, there were 52,239 and
60,575 subjects in the male and female analysis respec-
tively; for WHR, there were 30,713 and 38,016; for WHR
adjusted for BMI, there were 30,715 and 38,028; for WC,
there were 33,989 and 42,060; and for WC adjusted for
BMI, there were 34,059 and 42,226. We derived the corre-
lation between BMI and WHR and WC in males and
females from Table S8 of Heid et al.6 using a sample size
weighted average. We obtained the following correlation:
cor(BMI,WHR)female ¼ 0.42, cor(BMI,WHR)male ¼ 0.56,
cor(BMI,WC)female ¼ 0.84, cor(BMI,WC)male ¼ 0.86.
We noted that themajority of the SNPs (78%) had effects
in opposite direction for BMI and WHR/WC. We
confirmed through simulation that the expected propor-
tion of SNPs having effect in opposite direction in a model
where the genetic variant is associated with the outcome,5, 2015
but not the covariate, is smaller or equal to 50%.When two
traits are positively correlated and neither is associated
with the SNPs tested, the two sets of estimates (on BMI
and WHR/WC in this case) are also expected to be posi-
tively correlated (Figure S3A), and therefore most SNPs
should display effects in the same direction, i.e., the frac-
tion of SNPs with effects in the same direction will be
>0.5. In the presence of a true association between the
SNP and the outcome, this fraction decreases toward 0.5
(Figure S3B). Using this lower, conservative expected frac-
tion of 0.5, the probability that the fraction SNPs with
opposite effects is equal to or greater than the observed
fraction of 78% is p ¼ 5 3 103. These simulations also
show that the potential presence of an opposite effect
due to chance (i.e., bC ¼ 0 but bbCs0) would not impact
power in adjusted analysis. The intuition is that positive
correlation between the outcome and the covariate implies
that the estimates bbC and bbY follow the same pattern, i.e.,
when bbC is smaller than zero, bbY tend to be smaller than bY
and conversely. Therefore, the adjusted estimate bbYadj
which approximately equals bbY  bbCbrCY tends to change
toward the true estimate. Hence the p-value for bbYadj is
not influenced by bbC when bC ¼ 0 (Figure S3, lower panel).
Appendix D
Evaluation of Alternatives Approaches
This study and previous works (see Appendix B) showed
that variables that shared causal factors with the outcome
should not be used for adjustment purposes. We explored
two potential solutions in a GWAS context to address situ-
ation where bC s 0. One first solution consists in using
Cadj.g, the residual of C adjusted for the effect of g. Because
the genetic effect is removed from the C, adjusting the pri-
mary outcome Y for Cadj.g would a priori not induce bias.
However, the problem of deriving this residual is that it de-
pends on the accuracy of bbC, the estimate of the effect of G
on C, which will be accurate for infinite sample size but
noisy for small sample size. Hence, while adjusting C for
the true effect of g removes the bias, a ‘‘residual bias’’ re-
mains when using the estimated Cadj.g (Figure S5). When
applied on a GWAS scale, it can actually introduce more
bias that the standard adjustment. As the vast majority of
the SNPs are expected to be under the null, using Cadj.g
as a covariate can potentially introduce bias in all tests. Sec-
ond, we considered a stratified approach, where the ge-
netic effect on the primary outcome is evaluated in strata
defined by the covariate. Using the same simulation
scheme, we tested the marginal association between g
and Y independently in subjects with high versus low
values for C. As in the previous analysis, such a strategy
does not solve the bias issue (Figure S5). The intuition
here is that individuals with large values of C also
display large values for Y and g when both are positively
correlated with C (and conversely). Hence removing those
subjects induces a negative correlation between Y and gThe Americ(Figure S6). Overall we did not identify any general solu-
tion to this issue in the literature. However, for the very
specific case where the latent variables that explain the cor-
relation between the C and Y have been measured, some
proposed a two-steps adjustment procedure that might
correct for the bias.14 Although this approach might be
relevant for that specific scenario, whenever the latent
variables are unmeasured—as assumed in this study—the
proposed two-step approach does not solve the issue
(Figure S5).Supplemental Data
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